ProShares Ultra Nasdaq BiotechnologyBIB

$112.66

−10.0% last session

+41.3% YTD

Data as of 11/5/20264:00 PM ET · End-of-day

Dividend-adjusted return from the previous close · S&P 500 uses VOOBIBS&P 500 · VOO

Returns	1D	1M	3M	YTD	1Y	3Y	5Y	MAX
Total return	−10.0%	+4.8%	+5.9%	+41.3%	+65.4%	+178.6%	+26.4%	+1,445.4%
Peer average	−11.9%	−28.7%	−25.6%	−9.0%	−7.9%	+100.3%	+41.1%	—
S&P 500 · VOO	−4.4%	−5.7%	−4.9%	+8.4%	+9.8%	+82.2%	+71.6%	—

Key Statistics

Open all fund facts →

AUM: $108M
Expense ratio: 1.17%
Distribution yield: 0.2%
NAV: $125.22
Volume: 36K
Avg. volume 30D: 9K
High today: $124.12
Low today: $112.46
Previous close: $125.11
52-week high: $126.40
52-week low: $67.50
Our risk indicator: 5/5

BIB in One Breath

BIB Among An Index ETFs

YTD

#1UCOProShares+175.1%$420M

#2UCYBProShares+100.9%$12.4M

#3ERXDirexion+80.3%$279M

#4DIGProShares+79.1%$81.8M

#5GUSHDirexion+72.6%$228M

#6TEXUDirexion+58.8%$3.7M

#7TBXUDirexion+48.0%$3.5M

#8BIBProShares+41.3%$108M

#9RXLProShares+36.4%$119M

End-of-day Nov 5, 2026 · 85 An index ETFs by YTD

$10,000 in BIB

$10,000 in BIB became

$12,640

In the S&P 500 (VOO)

$17,156

Total return, dividends in · Oct 28, 2021 – Nov 5, 2026 · S&P 500 uses VOO

BIB’s Top Holdings

Today

IQMMProshares Genius Mny Mkt Etf15.8%GILD5.5%AMGN5.1%VRTX4.6%MRNA3.9%REGN3.5%RVMD1.6%BIIB1.4%ILMN1.3%RPRX1.1%ROIV1.0%UTHR1.0%ARGX1.0%INCY0.9%INSM0.9%GH0.9%VTRSALNYMEDPEXELNBIXASND252 more

IQMMProshares Genius Mny Mkt Etf15.8%GILD5.5%AMGN5.1%VRTX4.6%MRNA3.9%REGN3.5%RVMDBIIBILMNRPRXROIVUTHR262 more

BiotechnologyAsset Management - BondsDrug Manufacturers - GeneralMedical - DiagnosticsDrug Manufacturers - SpecialtyMedical - Pharmaceuticals

ProShares BIB · 274 holdings · tile size = share of the fund · as of Nov 5, 2026

What BIB Holds

Today

Biotechnology36.7%

VRTX 4.6 · MRNA 3.9 · REGN 3.5 · RVMD 1.6 · ROIV 1.0 · UTHR · ARGX

Asset Management - Bonds15.8%

IQMM 15.8

Drug Manufacturers - General12.4%

GILD 5.5 · AMGN 5.1 · BIIB 1.4 · SNY

Medical - Diagnostics & Research3.2%

ILMN 1.3 · GH · MEDP · GRAL · VCYT

Drug Manufacturers - Specialty & Generic1.6%

VTRS · ALKS · AMRX · SUPN

Medical - Pharmaceuticals1.3%

RPRX 1.1 · KNSA

Medical - Healthcare Information Services0.5%

TEM

ProShares BIB · share of the fund by industry · as of Nov 5, 2026

Proshares’ Share of BIB

Today

15.8%

$158 of every $1,000 in BIB is Proshares

Proshares held by BIB

$17.0M

Most Proshares per dollar

IQQQ15.0%

ISPY13.1%

CSM3.1%

ProShares BIB · each square = $10 of $1,000 · as of Nov 5, 2026

BIB’s Share of An Index ETFs

Today

0.1%

of the $138B in 404 An index ETFs

BIB$108M0.1%

TQQQ$33.2B24.1%

SOXL$19.9B14.5%

401 others$84.7B61.4%

An index ETF AUM · Nov 5, 2026

BIB Fee per $100 vs Peers

Today

$1.17a year
per $100

$117 a year on $10,000

SSO$0.88

ROM$0.93

USD$0.94

QLD$0.96

BIB$1.17

BITX$2.75

Expense ratio · An index peers · Nov 5, 2026

Inside BIB

274 holdings · as of Nov 5, 2026

BIB

ProShares Ultra Nasdaq Biotechnology

Today

Biotechnology36.7%VRTX4.6%MRNA3.9%REGN3.5%RVMDROIVUTHRARGXINCYINSMALNYEXELNBIX67 more holdings14.9% of the fundAsset Management - Bonds15.8%IQMMProshares Genius MNY MKT ETF15.8%Drug Manufacturers - General12.4%GILD5.5%AMGN5.1%BIIBMedical - Diagnostics3.2%ILMNGH MEDPDrug Manufacturers - Specialty1.6%VTRSMedical - Pharmaceuticals1.3%RPRXOther28.4%

Biotechnology36.7%VRTX4.6%MRNA3.9%REGN3.5%RVMDROIVUTHR75 more holdings21.0% of the fundAsset Management - Bonds15.8%IQMM15.8%Drug Manufacturers - General12.4%GILD5.5%AMGN5.1%BIIBILMNGH MEDPVTRSRPRXOther28.4%

#	Ticker	Company	Weight ▼
1	IQMM	Proshares Genius MNY MKT ETF	15.80%
2	GILD	Gilead Sciences	5.49%
3	AMGN	Amgen	5.12%
4	VRTX	Vertex Pharmaceuticals	4.64%
5	MRNA	Moderna	3.89%
6	REGN	Regeneron Pharmaceuticals	3.55%
7	RVMD	Revolution Medicines	1.61%
8	BIIB	Biogen	1.42%
9	ILMN	Illumina	1.29%
10	RPRX	Royalty Pharma -	1.13%

BiotechnologyAsset Management - BondsDrug Manufacturers - GeneralMedical - DiagnosticsDrug Manufacturers - SpecialtyMedical - PharmaceuticalsMedical - Healthcare Information ServicesOther

ProShares BIB · current holdings by weight · as of Nov 5, 2026 · each tile is one holding · top 20 = 52.6%

How It Compares

BIB

ProShares Ultra Nasdaq Biotechnology’s Peers

YTD


QLD	ProSharesRead Desk	0.96%	+2.8%	+0.1%	$12.8B
SSO	ProSharesRead Desk	0.88%	+10.3%	+11.9%	$8.4B
USD	ProSharesRead Desk	0.94%	−3.9%	−11.3%	$2.0B
ROM	ProSharesRead Desk	0.93%	+13.7%	+7.5%	$1.1B
BITX	Volatility SharesRead Desk	2.75%	−42.3%	−58.8%	$1.1B
BIB	ProSharesThis fundRead Desk	1.17%	+41.3%	+65.4%	$108M

An index peers · YTD and past-year returns · as of Nov 6, 2026 · sorted by AUM

Head to Head

Put BIB head to head with QLD →

QLD vs BIB

YTD

QLDProShares · An indexBIBProShares · An index

Year to date

+2.8%

+41.3%

BIB wins+38.5 pts

Past year

+0.1%

+65.4%

BIB wins+65.3 pts

Fee

0.96%

1.17%

QLD winslower fee

Yield

0.2%

Level

AUM

$12.8B

$108M

QLD118.6× more

2–1BIB wins

ProShares QLD and ProShares BIB · year-to-date · as of Nov 6, 2026 · AUM not scored

BIB vs VOO

YTD

BIB · ProShares Ultra Nasdaq Biotechnology

+41.3%

VOO · S&P 500

+8.4%

Gap

32.9 pts

ProShares BIB and Vanguard VOO · YTD total return · as of Nov 6, 2026

BIB vs Its Peer Average

YTD

BIBAvsBPeer average

1D−10.0%−11.9%

1M+4.8%−28.7%

3M+5.9%−25.6%

YTD+41.3%−9.0%

1Y+65.4%−7.9%

3Y+178.6%+100.3%

5Y+26.4%+41.1%

6–1BIB wins

229 An index peers · each row scaled to its leader

The Details

BIB

Risk

5/5our risk indicator

CalmerBumpier

Volatility · 1Y46.11%

Deepest drop · 1Y−17.9%

Lowest point · 5Y−56.9%

52-week range

$112.66

$67.50−10.9% from the high$126.40

ProShares BIB · past-year price moves · as of Nov 6, 2026

BIB

Fund Facts

Today

2010launched Apr 7

Tracks[…]

Exchange · CUSIPNASDAQ · 74347R214

StructureETF

Leverage2x

Cost on $10,000$117 a year

Go deeper

Prospectus & documents Trading & liquidity Fees & costs Distributions

ProShares BIB · fund facts · as of Nov 6, 2026

BIB

Payouts by Year

$0.0826per share, Sep 2026

Distribution yield0.2%

PaidEvery quarter

Latest ex-date · paidSep 23 · Sep 29, 2026

12 payouts added up$1.62 a share

ProShares BIB · distributions by ex-date · 2022–2026

All Fund FactsDocuments · trading · fees · every payout

Prospectus & Documents

SEC reported portfolio · 2026-08-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2026-05-31 ↗SEC reported portfolio · 2026-02-28 ↗SEC reported portfolio · 2025-11-30 ↗SEC reported portfolio · 2025-08-31 ↗

Trading & Liquidity

Net asset value$125.22

Premium / discount[…]

Median spread · 30D[…]

Volume today36K

Average volume · 30D9K

Shares outstanding[…]

Options[…]

Fees & Costs

Net expense ratio1.17%

Gross expense ratio[…]

Management fee[…]

Cost on $10,000 a year$117.00

Our risk indicator5/5

Estimated yearly cost excludes trading costs and assumes constant assets.

Distributions

Ex-date	Paid	Per share
Sep 23, 2026	Sep 29, 2026	$0.0826
Mar 25, 2026	Mar 31, 2026	$0.0071
Dec 24, 2025	Dec 31, 2025	$0.13
Sep 24, 2025	Sep 30, 2025	$0.18
Jun 25, 2025	Jul 1, 2025	$0.17
Mar 26, 2025	Apr 1, 2025	$0.13
Dec 23, 2024	Dec 31, 2024	$0.40
Sep 25, 2024	Oct 2, 2024	$0.15
Jun 26, 2024	Jul 3, 2024	$0.26
Mar 20, 2024	Mar 27, 2024	$0.0403
Dec 20, 2023	Dec 28, 2023	$0.0384
Dec 22, 2022	Dec 30, 2022	$0.0199

Issuer contentFrom ProSharesHear the strategy from the people behind BIB.No issuer videos have been published for this fund.Are you the issuer? Claim this fund →